Navellier & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Navellier & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-920	Closed	-$569K	–	362
2024 Q3	$569K	Hold	920	–	–	0.08%	199
2024 Q2	$509K	Hold	920	–	–	0.06%	240
2024 Q1	$535K	Hold	920	–	–	0.07%	229
2023 Q4	$488K	Hold	920	–	–	0.07%	231
2023 Q3	$466K	Buy	+920	New	+$490K	0.08%	209
2014 Q4	–	Sell	-590,578	Closed	-$71.9M	–	356
2014 Q3	$71.9M	Sell	590,578 -78,390	-12%	-$9.53M	3.61%	3
2014 Q2	$78.9M	Sell	668,968 -23,428	-3%	-$2.76M	3.57%	4
2014 Q1	$83.3M	Sell	692,396 -16,208	-2%	-$1.93M	3.88%	1
2013 Q4	$78.9M	Sell	708,604 -84,727	-11%	-$8.42M	3.56%	3
2013 Q3	$73.1M	Sell	793,331 -10,255	-1%	-$927K	2.16%	5
2013 Q2	$68M	Buy	+803,586	New	+$66.9M	3.24%	5

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Navellier & Associates's TMO Position: Q4 2024 in Review

Navellier & Associates sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 920 shares — an estimated $569K sold.

Navellier & Associates first reported a position in TMO in Q2 2013 and held it in 11 quarters. The position peaked at $83.3M in Q1 2014. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Navellier & Associates reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Navellier & Associates sold 920 Thermo Fisher Scientific shares in Q4 2024, an estimated $569K.
Navellier & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 11 quarters.
Navellier & Associates's Thermo Fisher Scientific position peaked at $83.3M in Q1 2014.
2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Navellier & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.